Original Research
Published on 17 Feb 2026
Efficacy and safety in the short-to-intermediate term of advanced combination therapy with upadacitinib for refractory Crohn’s disease: real-world evidence from eastern China
in Gastroenterology
- 124 views
Original Research
Published on 17 Feb 2026
in Gastroenterology
Original Research
Published on 17 Feb 2026
in Public Mental Health
Original Research
Published on 17 Feb 2026
in Quantum Engineering and Technology
Correction
Published on 17 Feb 2026
in Public Health and Nutrition
Original Research
Published on 17 Feb 2026
in Cancer Immunity and Immunotherapy
Original Research
Published on 17 Feb 2026
in Cardiac Electrophysiology
Review
Published on 17 Feb 2026
in Fungi-Animal Interactions
Original Research
Published on 17 Feb 2026
in STEM Education
Original Research
Published on 17 Feb 2026
in Plant-Soil Interactions
Correction
Published on 17 Feb 2026
in Integrative Physiology
Original Research
Published on 17 Feb 2026
in Plant Metabolism and Chemodiversity
Original Research
Published on 17 Feb 2026
in Geotechnical Engineering
Correction
Published on 17 Feb 2026
in Psychology of Aging
Correction
Published on 17 Feb 2026
in Drugs Outcomes Research and Policies
Mini Review
Published on 17 Feb 2026
in Atherosclerosis and Vascular Medicine
Original Research
Published on 17 Feb 2026
in Animal Nutrition and Metabolism